An experimental compound appears to improve metabolic abnormalities associated with obesity, according to a preliminary study led by researchers at the National Institutes of Health, A report of the study, which was conducted with obese mice, appears online today in the Journal of Clinical Investigation.
View full post on National Institutes of Health (NIH) News Releases